课题基金 / 基金详情

SYNTHESIS OF CONGENERS & PRODRUGS

SYNTHESIS OF CONGENERS & PRODRUGS
同系物的合成
批准号:
2852561
负责人:
DAVID C. BAKER
金额:
$21.58万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-09-30 至 2001-09-29

项目摘要

项目成果

DAVID C. BAKER的其他基金

相关文献

中文摘要
翻译
这个项目的具体目标是设计和合成 以下是: 1.具有确认活性的先导化合物的同系物,以增强 活力或效力。 2.具有结构修饰的前药,可提供改进的 药代动力学,改变药物传输,提高生物利用度 通过增加水的溶解度,或增加化学稳定性。 3.其他同时具有同类元素和元素的改变的结构 前药。引线的修饰也可以包括部分结构。 4.与天然产品有关的化合物,例如生物碱、 杂环、核苷、多肽。
英文摘要
The specific objectives of this project are to design and synthesize the following: 1. Congeners of lead compounds having confirmed activity, to enhance activity or potency. 2. Prodrugs with structural modifications that may provide improved pharmacokinetics, altered drug transport, improved bio-availability through increased water solubility, or increased chemical stability. 3. Other altered structures that possess elements of both congener and prodrug. Modifications of a lead may also include partial structures. 4. Compounds related to natural products, e.g., such as alkaloids, heterocycles, nucleosides, peptides.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tyoloindicines--Potent Antitumor Compounds
Tyoloindicines--Potent Antitumor Compounds
Tyoloindicines--Potent Antitumor Compounds
ANTIMETASTATIC OLIGOSACCHARIDES FROM HYALURONIC ACID